Immunobiology and Transplant Science Center, Houston Methodist Hospital and Houston Methodist Research Institute, Texas Medical Center, Houston, TX, United States; Center for Organ Transplantation, The 3rd Xiangya Hospital, Central South University, Changsha, Hunan, China.
Immunobiology and Transplant Science Center, Houston Methodist Hospital and Houston Methodist Research Institute, Texas Medical Center, Houston, TX, United States.
Cytokine Growth Factor Rev. 2017 Oct;37:47-55. doi: 10.1016/j.cytogfr.2017.07.004. Epub 2017 Jul 17.
CD4+ T cells have the capacity to differentiate into various T helper (Th) cell subsets after activation, and by acquiring distinct cytokine profiles and effector functions, they regulate the nature as well as the outcomes of immune responses. Th9 cells are a relatively new member in the Th cell family. The signature cytokine for Th9 cells is IL-9, a cytokine in the IL-2Rγc-chain family. Over the past few years, there has been an explosion of knowledge on the roles of Th9 cells in immunity and immunopathology, but the exact mechanisms in the control of Th9 cells remain poorly defined. This apparent paradox presents both challenges and opportunities. Here we review recent advances in our understanding of the fundamental biology of IL-9 and Th9 cells, highlighting the challenges and unanswered questions in the field. We also discuss potential opportunities in targeting Th9 cells for therapeutic purposes in the clinic.
CD4+ T 细胞在激活后具有分化为各种辅助性 T 细胞(Th)亚群的能力,通过获得不同的细胞因子谱和效应功能,它们调节免疫反应的性质和结果。Th9 细胞是 Th 细胞家族中的一个相对较新的成员。Th9 细胞的标志性细胞因子是 IL-9,一种白细胞介素 2 受体 γc 链家族的细胞因子。在过去的几年中,人们对 Th9 细胞在免疫和免疫病理学中的作用有了大量的了解,但 Th9 细胞的控制的确切机制仍未得到明确界定。这种明显的悖论既带来了挑战,也带来了机遇。在这里,我们回顾了我们对 IL-9 和 Th9 细胞基础生物学的理解的最新进展,强调了该领域的挑战和未解决的问题。我们还讨论了在临床上针对 Th9 细胞进行治疗的潜在机会。